Company Profile
LEO Pharma s.r.o., founded in 1992, is a prominent chemical company based in the Czech Republic, known for its expertise in developing and manufacturing high-quality chemical solutions. The company has established itself as a trusted name in the chemical sector, focusing on innovation and client satisfaction across various industries, including pharmaceuticals, food and beverage, and environmental protection.
Situated in the Gemini Building B in Prague, LEO Pharma is conveniently located near public transport and close to numerous attractions, making it easily accessible.
With state-of-the-art facilities that comply with the highest quality and safety standards, LEO Pharma is equipped with advanced laboratories, production units, and warehouses, enabling efficient and effective product manufacturing.
Committed to sustainable practices, LEO Pharma actively works to minimize its environmental footprint by reducing carbon emissions and implementing recycling initiatives, while also ensuring ethical business conduct and product safety.
VIEW MORE VIEW LESS
Product List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
Alfacalcidol |
1,3-Cyclohexanediol,5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-1,5-dimethylhexyl]octahydro-7a-methyl-4H-inden-4-ylidene]ethylidene]-4-methylene-,(1R,3R)-;9,10-Secocholesta-5,7,10(19)-triene-1,3-diol,(1α,3β,5Z,7E)-;(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-1,5-Dimethylhexyl]octahydro-7a-methyl-4H-inden-4-ylidene]ethylidene]-4-methylene-1,3-cyclohexanediol;1α-Hydroxycholecalciferol;1α-Hydroxyvitamin D3;1-Hydroxycholecalciferol;1-Hydroxyvitamin D3;Alfacalcidol;Un Alpha;α-Calcidol;Alfarol;Alphacalcidol;Oxydevit;Alpharol;Bondiol;Un Alfa;Etalpha;1α(OH)D3;Alpha D3;EinsAlpha;(1S)-Hydroxycalciol;Tevabone;125324-15-4;41461-06-7;43157-29-5;43217-90-9 |
41294-56-8 | Inquiry | |
Calcipotriene |
1,3-Cyclohexanediol,5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R,2E,4S)-4-cyclopropyl-4-hydroxy-1-methyl-2-buten-1-yl]octahydro-7a-methyl-4H-inden-4-ylidene]ethylidene]-4-methylene-,(1R,3S,5Z)-;9,10-Secochola-5,7,10(19),22-tetraene-1,3,24-triol,24-cyclopropyl-,(1α,3β,5Z,7E,22E,24S)-;(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R,2E,4S)-4-Cyclopropyl-4-hydroxy-1-methyl-2-buten-1-yl]octahydro-7a-methyl-4H-inden-4-ylidene]ethylidene]-4-methylene-1,3-cyclohexanediol;MC 903;Calcipotriol;Dovonex;Daivonex;Calcipotriene;Calciptriol;Psorcutan;PRI 2201;112828-00-9 |
112965-21-6 | Inquiry | |
Fusidine |
29-Nordammara-17(20),24-dien-21-oic acid,16-(acetyloxy)-3,11-dihydroxy-,(3α,4α,8α,9β,11α,13α,14β,16β,17Z)-;29-Nor-8α,9β,13α,14β-dammara-17(20),24-dien-21-oic acid,3α,11α,16β-trihydroxy-,16-acetate,(Z)-;Fusidic acid;(3α,4α,8α,9β,11α,13α,14β,16β,17Z)-16-(Acetyloxy)-3,11-dihydroxy-29-nordammara-17(20),24-dien-21-oic acid;Ramycin;SQ 16603;Fucithalmic;Fusidinic acid;NSC 56192;Flucidin;Foban;Fugen;Optifucin;Phudicin;Usidin;62-60-2;1386-65-8;1404-47-3;2618-21-5;313340-66-8 |
6990-06-3 | Inquiry | |
Mecillinam |
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,6-[[(hexahydro-1H-azepin-1-yl)methylene]amino]-3,3-dimethyl-7-oxo-,(2S,5R,6R)-;4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,6-[[(hexahydro-1H-azepin-1-yl)methylene]amino]-3,3-dimethyl-7-oxo-,[2S-(2α,5α,6β)]-;4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,6-[[(hexahydro-1H-azepin-1-yl)methylene]amino]-3,3-dimethyl-7-oxo-,(+)-;(2S,5R,6R)-6-[[(Hexahydro-1H-azepin-1-yl)methylene]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;6β-[(Hexahydro-1H-azepin-1-yl)methyleneamino]penicillanic acid;FL 1060;6-[[(Hexahydro-1H-azepin-1-yl)methylene]amino]penicillanic acid;Mecillinam;Penicillin Hx;Hexacillin;Amdinocillin;Hexapen;Coactin;51556-89-9;70178-27-7;73937-07-2;79580-20-4 |
32887-01-7 | Inquiry |